Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Ascentage, Ascletis, Biomx, Deciphera, Innocare, Innovent, Kazia, Lyell, Vivacta Bio.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Acadia, Amgen, Apellis, Bio-Thera, GSK, Immunitybio, Kymera, Merck, Novo Nordisk, Sobi, Stada.

Biopharma happenings, including deals and partnerships, and other news in brief: Cosette, Everest Medicines, Genmab, Geron, Hasten, Hyloris, Mayne, Merus.

Clinical updates, including data readouts and publications: AB Science, Anixa, Arcus, Ausperbio, Avenzo, Beyondspring, Cullgen, Innovent, Innoviva, Relay, Tenaya.

Biopharmas raising money in public or private financings, including: Alphyn, Contineum, Dyne, Enveric, Structure, Tenaya, Terns, Tetraneuron, Zegenex.

New hires and promotions in the biopharma industry, including: Oruka, Serina.

New hires and promotions in the med-tech industry, including: Envue Medical.

Med-tech firms raising money in public or private financings, including: Inspira Technologies, Impulse Dynamics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Radiopharm Theranostics.